Table 1.
Baseline demographics and clinical characteristics
| Standard of care N = 45 (%) | Intervention N = 46 (%) | P value | |
|---|---|---|---|
| Age at diagnosis | 29.4 (11.8) | 26.6 (11.9) | 0.41 |
| Age at admission | 35.6 (12.6) | 32.1 (11.4) | 0.33 |
| Male | 22 (52) | 21 (47) | 0.67 |
| Site | 0.41 | ||
| Toronto | 24 (53) | 20 (43) | |
| Calgary | 8 (18) | 12 (26) | |
| Vancouver | 5 (11) | 5 (11) | |
| Other | 8 (18) | 9 (20) | |
| Weekend admission | 6 (14) | 7 (16) | 0.94 |
| Admitting service | 0.89 | ||
| Gastroenterology | 26 (62) | 33 (73) | |
| Internal medicine | 13 (31) | 10 (22) | |
| Surgery | 3 (7) | 1 (2) | |
| Other | 0 (0) | 1 (2) | |
| Partial Mayo Score | 6.6 (1.8) | 6.5 (2.0) | 0.84 |
| Disease extent | 0.91 | ||
| Proctitis | 6 (14) | 5 (12) | |
| Left-sided | 16 (38) | 18 (42) | |
| Extensive | 20 (48) | 20 (47) | |
| Medical therapy | |||
| 5-aminosalicylate | 18 (43) | 16 (36) | 0.49 |
| Steroids | 21 (50) | 18 (40) | 0.45 |
| Thiopurine | 7 (17) | 3 (7) | 0.14 |
| Anti-TNF | 16 (38) | 12 (27) | 0.25 |
| Admission | |||
| Hemoglobin | 115 (24) | 117 (21) | 0.60 |
| Albumin | 34.1 (10.8) | 32.1 (6.8) | 0.27 |
| C-reactive protein | 62.5 (65.1) | 67.5 (67.7) | 0.76 |